Tardive Dyskinesia (TD) Treatment Market Report

Global and Region Tardive Dyskinesia (TD) Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：160
  • REPORT CODE：GMM965621
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Tardive Dyskinesia (TD) Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Tardive Dyskinesia (TD) Treatmentmarket, defines the market attractiveness level of Tardive Dyskinesia (TD) Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Tardive Dyskinesia (TD) Treatment industry, describes the types of Tardive Dyskinesia (TD) Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tardive Dyskinesia (TD) Treatment market and the development prospects and opportunities of Tardive Dyskinesia (TD) Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tardive Dyskinesia (TD) Treatment market in Chapter 13.

    By Player:

    • Biogen

    • Teva Pharma

    • Novartis

    • GlaxoSmithKline

    • Bayer AG

    • Pfizer

    • Neurocrine Biosciences

    • Sanofi

    • Johnson & Johnson

    • AstraZeneca

    By Type:

    • Valbenazine

    • Amantadine

    • Tetrabenazine

    • Clonazepam

    • Others

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Tardive Dyskinesia (TD) Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Tardive Dyskinesia (TD) Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Tardive Dyskinesia (TD) Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Tardive Dyskinesia (TD) Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Tardive Dyskinesia (TD) Treatment Market Analysis and Outlook to 2022

    • 7.1 Global Tardive Dyskinesia (TD) Treatment Consumption (2017-2022)

    • 7.2 United States Tardive Dyskinesia (TD) Treatment Consumption (2017-2022)

    • 7.3 Europe Tardive Dyskinesia (TD) Treatment Consumption (2017-2022)

    • 7.4 China Tardive Dyskinesia (TD) Treatment Consumption (2017-2022)

    • 7.5 Japan Tardive Dyskinesia (TD) Treatment Consumption (2017-2022)

    • 7.6 India Tardive Dyskinesia (TD) Treatment Consumption (2017-2022)

    • 7.7 South Korea Tardive Dyskinesia (TD) Treatment Consumption (2017-2022)

    8 Region and Country-wise Tardive Dyskinesia (TD) Treatment Market Analysis and Outlook to 2028

    • 8.1 Global Tardive Dyskinesia (TD) Treatment Consumption Forecast (2022-2028)

    • 8.2 United States Tardive Dyskinesia (TD) Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe Tardive Dyskinesia (TD) Treatment Consumption Forecast (2022-2028)

    • 8.4 China Tardive Dyskinesia (TD) Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan Tardive Dyskinesia (TD) Treatment Consumption Forecast (2022-2028)

    • 8.6 India Tardive Dyskinesia (TD) Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea Tardive Dyskinesia (TD) Treatment Consumption Forecast (2022-2028)

    9 Global Tardive Dyskinesia (TD) Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Tardive Dyskinesia (TD) Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Valbenazine Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Amantadine Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Tetrabenazine Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Clonazepam Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Tardive Dyskinesia (TD) Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Tardive Dyskinesia (TD) Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global Tardive Dyskinesia (TD) Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Valbenazine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Amantadine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Tetrabenazine Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Clonazepam Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Tardive Dyskinesia (TD) Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Tardive Dyskinesia (TD) Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Tardive Dyskinesia (TD) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Tardive Dyskinesia (TD) Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Tardive Dyskinesia (TD) Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Tardive Dyskinesia (TD) Treatment Market Competitive Analysis

    • 14.1 Biogen

      • 14.1.1 Biogen Company Details

      • 14.1.2 Biogen Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Biogen Tardive Dyskinesia (TD) Treatment Product and Service

    • 14.2 Teva Pharma

      • 14.2.1 Teva Pharma Company Details

      • 14.2.2 Teva Pharma Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Teva Pharma Tardive Dyskinesia (TD) Treatment Product and Service

    • 14.3 Novartis

      • 14.3.1 Novartis Company Details

      • 14.3.2 Novartis Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novartis Tardive Dyskinesia (TD) Treatment Product and Service

    • 14.4 GlaxoSmithKline

      • 14.4.1 GlaxoSmithKline Company Details

      • 14.4.2 GlaxoSmithKline Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GlaxoSmithKline Tardive Dyskinesia (TD) Treatment Product and Service

    • 14.5 Bayer AG

      • 14.5.1 Bayer AG Company Details

      • 14.5.2 Bayer AG Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bayer AG Tardive Dyskinesia (TD) Treatment Product and Service

    • 14.6 Pfizer

      • 14.6.1 Pfizer Company Details

      • 14.6.2 Pfizer Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Tardive Dyskinesia (TD) Treatment Product and Service

    • 14.7 Neurocrine Biosciences

      • 14.7.1 Neurocrine Biosciences Company Details

      • 14.7.2 Neurocrine Biosciences Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Neurocrine Biosciences Tardive Dyskinesia (TD) Treatment Product and Service

    • 14.8 Sanofi

      • 14.8.1 Sanofi Company Details

      • 14.8.2 Sanofi Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Sanofi Tardive Dyskinesia (TD) Treatment Product and Service

    • 14.9 Johnson & Johnson

      • 14.9.1 Johnson & Johnson Company Details

      • 14.9.2 Johnson & Johnson Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Johnson & Johnson Tardive Dyskinesia (TD) Treatment Product and Service

    • 14.10 AstraZeneca

      • 14.10.1 AstraZeneca Company Details

      • 14.10.2 AstraZeneca Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Tardive Dyskinesia (TD) Treatment

    • Figure Tardive Dyskinesia (TD) Treatment Picture

    • Table Global Tardive Dyskinesia (TD) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Tardive Dyskinesia (TD) Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Tardive Dyskinesia (TD) Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Tardive Dyskinesia (TD) Treatment Consumption by Country (2017-2022)

    • Figure United States Tardive Dyskinesia (TD) Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Tardive Dyskinesia (TD) Treatment Consumption and Growth Rate (2017-2022)

    • Figure China Tardive Dyskinesia (TD) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Tardive Dyskinesia (TD) Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Tardive Dyskinesia (TD) Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Tardive Dyskinesia (TD) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Tardive Dyskinesia (TD) Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Tardive Dyskinesia (TD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Tardive Dyskinesia (TD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Tardive Dyskinesia (TD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Tardive Dyskinesia (TD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Tardive Dyskinesia (TD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Tardive Dyskinesia (TD) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Valbenazine Consumption and Growth Rate (2017-2022)

    • Figure Global Amantadine Consumption and Growth Rate (2017-2022)

    • Figure Global Tetrabenazine Consumption and Growth Rate (2017-2022)

    • Figure Global Clonazepam Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Valbenazine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Amantadine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tetrabenazine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clonazepam Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Tardive Dyskinesia (TD) Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Tardive Dyskinesia (TD) Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table Biogen (Foundation Year, Company Profile and etc.)

    • Table Biogen Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Tardive Dyskinesia (TD) Treatment Product and Service

    • Table Teva Pharma (Foundation Year, Company Profile and etc.)

    • Table Teva Pharma Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharma Tardive Dyskinesia (TD) Treatment Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Tardive Dyskinesia (TD) Treatment Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Tardive Dyskinesia (TD) Treatment Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Tardive Dyskinesia (TD) Treatment Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Tardive Dyskinesia (TD) Treatment Product and Service

    • Table Neurocrine Biosciences (Foundation Year, Company Profile and etc.)

    • Table Neurocrine Biosciences Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurocrine Biosciences Tardive Dyskinesia (TD) Treatment Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Tardive Dyskinesia (TD) Treatment Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Tardive Dyskinesia (TD) Treatment Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Tardive Dyskinesia (TD) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Tardive Dyskinesia (TD) Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US